Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model

BACKGROUND: Toxoplasma is an important source of foodborne hospitalization with no safe and effective therapy against chronic or congenital Toxopalsmosis. Atovaquone is a drug of choice but not approved for use in congenital Toxoplasmosis. We hypothesized atovaquone to be safe and effective against...

Descripción completa

Detalles Bibliográficos
Autores principales: Oz, Helieh S., Tobin, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560658/
https://www.ncbi.nlm.nih.gov/pubmed/22936182
http://dx.doi.org/10.12659/MSM.883342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560658/
https://www.ncbi.nlm.nih.gov/pubmed/22936182
http://dx.doi.org/10.12659/MSM.883342

Ejemplares similares